Sisters Turn Adversity into Artistry with ‘Wheely Good Ceramics’

After a life-altering illness left Emily Kilby paralyzed at age 13, she discovered a new way to express her artistic passion by learning to paint with a brush in her mouth. Teaming up with her sister Olivia, who crafts the ceramic pieces, Emily applies her unique painting skills to create beautiful pottery for their business, Wheely Good Ceramics. Launched in 2022, their joint venture not only showcases their talents but also brings them closer, allowing them to enjoy precious moments together despite Emily’s disability. Their inspiring collaboration highlights the power of creativity and family support, turning personal challenges into a flourishing and joyful enterprise.

PrevPreviousWWII Veteran’s Grandson Returns Historic Flag to Japanese Family

NextA Traffic Stop Turns into a Life-Changing Career Path for Alabama WomanNext

Recent Articles

The 2026 Met Gala Was Absolutely Iconic, Here Are Some Of The Best Moments

May 5, 2026

Fashion’s biggest night delivered. The 2026 Met Gala themed “Costume Art,” with a dress code of “Fashion Is Art” took over the Metropolitan Museum of Art on Monday night, and the looks, surprises, and sheer spectacle did not disappoint. The undisputed headline of the evening was Beyoncé, who returned to

A 12-Year-Old Fighting Brain Cancer Raised $22 At A Lemonade Stand For Research And Then Something Incredible Happened

May 5, 2026

When 12-year-old Rowan Rieve learned that federal funding for childhood brain tumor research had been cut, he set up a lemonade and sweet tea stand with his friends, raised $22.25, and brought every coin to his next cancer appointment in a small plastic bag for the research team, telling his

Every Patient In This Bowel Cancer Trial Has Been Cancer Free For Nearly Three Years

May 5, 2026

In one of the most striking results from any cancer clinical trial in recent years, every single patient in a bowel cancer study has remained cancer-free for nearly three years after receiving a short course of immunotherapy before surgery, with zero relapses recorded in the entire cohort as of the